Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-07

Clinical Trial Update: Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM [Phase 4]

View source ↗

Summary

Phase 4 trial comparing azithromycin to doxycycline for anal chlamydia in men who have sex with men has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Doxycycline (Doxycycline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Anal Chlamydia Infection | Phase 4 | Status: COMPLETED | Results posted: 2021-01-07